145 related articles for article (PubMed ID: 12027100)
61. Hypocrellin B Encapsulated in Triphenyl Phosphonium-Modified Cationic Liposomes for Photodynamic Treatment of Exudative Age-Related Macular Degeneration.
Chen H; Deng H; Zou X; Zhao J
J Biomed Nanotechnol; 2019 Dec; 15(12):2305-2320. PubMed ID: 31748013
[TBL] [Abstract][Full Text] [Related]
62. Photodynamic inhibitory effects of three perylenequinones on human colorectal carcinoma cell line and primate embryonic stem cell line.
Ma L; Tai H; Li C; Zhang Y; Wang ZH; Ji WZ
World J Gastroenterol; 2003 Mar; 9(3):485-90. PubMed ID: 12632502
[TBL] [Abstract][Full Text] [Related]
63. Investigating the effect of ciliary body photodynamic therapy in a glaucoma mouse model.
Matsubara A; Nakazawa T; Husain D; Iliaki E; Connolly E; Michaud NA; Gragoudas ES; Miller JW
Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2498-507. PubMed ID: 16723462
[TBL] [Abstract][Full Text] [Related]
64. Chlorophyllin-M: A new substance for photodynamic therapy in the retina and choroid.
Salomao GH; Fernandes AU; Baptista MS; Tardivo JP; Christofolini DM; Correa JA
Lasers Surg Med; 2015 Jul; 47(5):421-5. PubMed ID: 25976110
[TBL] [Abstract][Full Text] [Related]
65. [Potential of photodynamic therapy with a second-generation sensitizer: mono-L-aspartyl chlorin e6].
Mori K; Ohta M; Sano A; Yoneya S; Sonoda M; Kaneda A; Sato Y
Nippon Ganka Gakkai Zasshi; 1997 Feb; 101(2):134-40. PubMed ID: 9124093
[TBL] [Abstract][Full Text] [Related]
66. [A new approach for studying the retinal and choroidal circulation].
Yoneya S
Nippon Ganka Gakkai Zasshi; 2004 Dec; 108(12):836-61; discussion 862. PubMed ID: 15656089
[TBL] [Abstract][Full Text] [Related]
67. Photodynamic therapy of circumscribed choroidal hemangioma.
Porrini G; Giovannini A; Amato G; Ioni A; Pantanetti M
Ophthalmology; 2003 Apr; 110(4):674-80. PubMed ID: 12689885
[TBL] [Abstract][Full Text] [Related]
68. Clinical evaluation of experimentally induced choroidal neovascularizations in pigmented rabbits by subretinal injection of lipid hydroperoxide and consecutive preliminary photodynamic treatment with Tookad.
Framme C; Sachs HG; Kobuch K; Flucke B; Birngruber R
Ophthalmologica; 2008; 222(4):254-64. PubMed ID: 18525218
[TBL] [Abstract][Full Text] [Related]
69. Ocular changes after photodynamic therapy.
Tzekov R; Lin T; Zhang KM; Jackson B; Oyejide A; Orilla W; Kulkarni AD; Kuppermann BD; Wheeler L; Burke J
Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):377-85. PubMed ID: 16384988
[TBL] [Abstract][Full Text] [Related]
70. Photodynamic effects on choroidal neovascularization and physiological choroid.
Schmidt-Erfurth U; Michels S; Barbazetto I; Laqua H
Invest Ophthalmol Vis Sci; 2002 Mar; 43(3):830-41. PubMed ID: 11867605
[TBL] [Abstract][Full Text] [Related]
71. Photodynamic effectiveness and vasoconstriction in hairless mouse skin after topical 5-aminolevulinic acid and single- or two-fold illumination.
van der Veen N; Hebeda KM; de Bruijn HS; Star WM
Photochem Photobiol; 1999 Dec; 70(6):921-9. PubMed ID: 10628304
[TBL] [Abstract][Full Text] [Related]
72. Photodynamic therapy of transitional cell carcinoma multicellular tumor spheroids with hypericin.
Kamuhabwa AA; Huygens A; De Witte PA
Int J Oncol; 2003 Nov; 23(5):1445-50. PubMed ID: 14532989
[TBL] [Abstract][Full Text] [Related]
73. Preclinical studies in normal canine prostate of a novel palladium-bacteriopheophorbide (WST09) photosensitizer for photodynamic therapy of prostate cancers.
Chen Q; Huang Z; Luck D; Beckers J; Brun PH; Wilson BC; Scherz A; Salomon Y; Hetzel FW
Photochem Photobiol; 2002 Oct; 76(4):438-45. PubMed ID: 12405153
[TBL] [Abstract][Full Text] [Related]
74. Selective photodynamic therapy for neovascular age-related macular degeneration with polypoidal choroidal neovascularization.
Eandi CM; Ober MD; Freund KB; Slakter JS; Yannuzzi LA
Retina; 2007 Sep; 27(7):825-31. PubMed ID: 17891004
[TBL] [Abstract][Full Text] [Related]
75. Hypocrellin B-encapsulated nanoparticle-mediated rev-caspase-3 gene transfection and photodynamic therapy on tumor cells.
Bai D; Xia X; Yow CM; Chu ES; Xu C
Eur J Pharmacol; 2011 Jan; 650(2-3):496-500. PubMed ID: 20970418
[TBL] [Abstract][Full Text] [Related]
76. Photodynamic therapy of murine fibrosarcoma with topical and systemic administration of hypericin.
Cavarga I; Brezáni P; Cekanová-Figurová M; Solár P; Fedorocko P; Miskovský P
Phytomedicine; 2001 Sep; 8(5):325-30. PubMed ID: 11695874
[TBL] [Abstract][Full Text] [Related]
77. [Photodynamic therapy of pigmented choroidal melanomas in rabbits].
Hu L; Wu X; Song Y; Young LH; Gragoudas ES
Zhonghua Yan Ke Za Zhi; 2002 Aug; 38(8):491-4. PubMed ID: 12410990
[TBL] [Abstract][Full Text] [Related]
78. Histomorphological changes in murine fibrosarcoma after hypericin-based photodynamic therapy.
Bobrov N; Cavarga I; Longauer F; Rybárová S; Fedorocko P; Brezáni P; Miskovský P; Mirossay L; Stubna J
Phytomedicine; 2007 Feb; 14(2-3):172-8. PubMed ID: 17095201
[TBL] [Abstract][Full Text] [Related]
79. Photoinduced antitumour effect of hypericin can be enhanced by fractionated dosing.
Cavarga I; Brezáni P; Fedorocko P; Miskovský P; Bobrov N; Longauer F; Rybárova S; Mirossay L; Stubna J
Phytomedicine; 2005 Sep; 12(9):680-3. PubMed ID: 16194057
[TBL] [Abstract][Full Text] [Related]
80. Verteporfin photodynamic therapy in the rat model of choroidal neovascularization: angiographic and histologic characterization.
Zacks DN; Ezra E; Terada Y; Michaud N; Connolly E; Gragoudas ES; Miller JW
Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2384-91. PubMed ID: 12091441
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
